Prudential Financial’s Harmony Biosciences HRMY Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$2.29M	Buy	81,874 +11,750	+17%	+$385K	﹤0.01%	1261
2025 Q4	$2.62M	Buy	70,124 +11,958	+21%	+$393K	﹤0.01%	1187
2025 Q3	$1.6M	Sell	58,166 -93,420	-62%	-$3.22M	﹤0.01%	1459
2025 Q2	$4.79M	Buy	151,586 +47,803	+46%	+$1.54M	0.01%	925
2025 Q1	$3.44M	Buy	103,783 +43,872	+73%	+$1.57M	﹤0.01%	1018
2024 Q4	$2.06M	Buy	59,911 +28,650	+92%	+$984K	﹤0.01%	1289
2024 Q3	$1.25M	Sell	31,261 -2,810	-8%	-$98.7K	﹤0.01%	1767
2024 Q2	$1.03M	Sell	34,071 -3,000	-8%	-$90.2K	﹤0.01%	1823
2024 Q1	$1.24M	Sell	37,071 -440	-1%	-$14.1K	﹤0.01%	1715
2023 Q4	$1.21M	Sell	37,511 -29,231	-44%	-$816K	﹤0.01%	1722
2023 Q3	$2.19M	Sell	66,742 -2,948	-4%	-$102K	﹤0.01%	1315
2023 Q2	$2.45M	Buy	69,690 +13,011	+23%	+$449K	﹤0.01%	1282
2023 Q1	$1.85M	Sell	56,679 -11,745	-17%	-$535K	﹤0.01%	1390
2022 Q4	$3.77M	Buy	68,424 +347	+0.5%	+$19.1K	0.01%	994
2022 Q3	$3.02M	Buy	68,077 +5,490	+9%	+$268K	0.01%	1090
2022 Q2	$3.05M	Sell	62,587 -27,680	-31%	-$1.25M	﹤0.01%	1150
2022 Q1	$4.39M	Buy	90,267 +66,112	+274%	+$2.7M	0.01%	1044
2021 Q4	$1.03M	Buy	+24,155	New	+$963K	﹤0.01%	1866